Activator of HSP90 ATPase 1 mRNA 3'-untranslated region (AHSA1 mRNA 3'-UTR) (AHSA1 mRNA 3'-UTR)

AHSA1 (Activator of HSP90 ATPase 1) is a potent co-chaperone that stimulates the ATPase activity of the heat shock protein 90 (HSP90) complex, which is essential for the maturation and stability of numerous client proteins (UniProt Q8NBP7). The 3'-untranslated region (3'-UTR) of the AHSA1 mRNA serves as a critical regulatory domain for post-transcriptional control, influencing mRNA stability and translation (PubMed: 28819143). In neurodegenerative conditions like Alzheimer's disease, AHSA1 levels are often elevated, promoting the accumulation of toxic, hyperphosphorylated Tau protein (PubMed: 28819143). Therapeutic strategies targeting the AHSA1 mRNA 3'-UTR, such as antisense oligonucleotides (ASOs), aim to reduce AHSA1 protein expression to facilitate the clearance of these pathological aggregates (Ionis Pharmaceuticals). Additionally, AHSA1 knockdown has shown potential in oncology by destabilizing oncogenic HSP90 clients, thereby inhibiting tumor progression (PubMed: 30254015). This mRNA region is thus a high-value target for precision medicine using RNA-based therapeutics. By specifically binding to the 3'-UTR, ASOs can trigger RNase H-mediated degradation of the transcript, leading to a sustained reduction in the co-chaperone's activity. This approach offers a more targeted alternative to broad HSP90 inhibition, which is often limited by systemic toxicity.

Other names

AHA1 mRNA 3'-UTRActivator of 90 kDa heat shock protein ATPase homolog 1 mRNA 3'-UTRhAha1 mRNA 3'-UTR

Antisense-mediated mRNA degradation (RNase H-dependent) or translational inhibition to reduce AHSA1 protein expression.